title: Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.
abstract: The metabotropic glutamate subtype 1 (mGluR1), a member of the metabotropic glutamate receptors, is a therapeutic target for neurological disorders. However, due to the lower subtype selectivity of mGluR1 orthosteric compounds, a new targeted strategy, known as allosteric modulators research, is needed for the treatment of mGluR1-related diseases. Recently, the structure of the seven-transmembrane domain (7TMD) of mGluR1 has been solved, which reveals the binding site of allosteric modulators and provides an opportunity for future subtype-selectivity drug design. In this study, a series of computer-aided drug design methods were utilized to discover potential mGluR1 negative allosteric modulators (NAMs). Pharmacophore models were constructed based on three different structure types of mGluR1 NAMs. After validation using the built-in parameters and test set, the optimal pharmacophore model of each structure type was selected and utilized as a query to screen the Traditional Chinese Medicine Database (TCMD). Then, three different hit lists of compounds were obtained. Molecular docking was used based on the latest crystal structure of mGluR1-7TMD to further filter these hits. As a compound with high QFIT and LibDock Score was preferred, a total of 30 compounds were retained. MD simulation was utilized to confirm the stability of potential compounds binding. From the computational results, thesinine-4'-O-β-d-glucoside, nigrolineaxanthone-P and nodakenin might exhibit negative allosteric moderating effects on mGluR1. This paper indicates the applicability of molecular simulation technologies for discovering potential natural mGluR1 NAMs from Chinese herbs.
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. jiangludi_52@163.com.
authors.forename: Ludi
authors.initials: L
authors.lastname: Jiang
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. wzhangxb@126.com.
authors.forename: Xianbao
authors.initials: X
authors.lastname: Zhang
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. chenxi_cx95@163.com.
authors.forename: Xi
authors.initials: X
authors.lastname: Chen
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. heyusue@163.com.
authors.forename: Yusu
authors.initials: Y
authors.lastname: He
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. b20100222012@163.com.
authors.forename: Liansheng
authors.initials: L
authors.lastname: Qiao
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. zhangyanling@bucm.edu.cn.
authors.forename: Yanling
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: Key Laboratory of TCM-Information Engineer of State Administration of TCM, School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. lidoc2727@163.com.
authors.forename: Gongyu
authors.initials: G
authors.lastname: Li
authors.affiliation: Department of Chemistry, Capital Normal University, Beijing 100048, China. cnuxiangyh@163.com.
authors.forename: Yuhong
authors.initials: Y
authors.lastname: Xiang
mesh_terms: D000494:Allosteric Regulation; D000495:Allosteric Site; D003374:Coumarins / Q000737:chemistry*; D055808:Drug Discovery; D004365:Drugs, Chinese Herbal / Q000737:chemistry*; D005960:Glucosides / Q000737:chemistry*; D057166:High-Throughput Screening Assays; D006801:Humans; D008024:Ligands; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D009005:Monosaccharides / Q000737:chemistry*; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011763:Pyrrolizidine Alkaloids / Q000737:chemistry*; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors* / Q000737:chemistry; D014584:User-Computer Interface; D044004:Xanthones / Q000737:chemistry*
chemical_list: D003374:Coumarins; D004365:Drugs, Chinese Herbal; D005960:Glucosides; D008024:Ligands; D009005:Monosaccharides; D011763:Pyrrolizidine Alkaloids; D018094:Receptors, Metabotropic Glutamate; D044004:Xanthones; C104077:metabotropic glutamate receptor type 1; C471579:nodakenin
keywords: MD; NAMs; TCM; docking; mGluR1; pharmacophore; virtual